Cerebrovascular disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age = 18; age =85 2) Those who plan to receive cerebral angiography 3) Voluntarily participated in the experiment and signed the informed consent
Exclusion criteria
Exclusion criteria: 1) Preoperative mRS Score > 2 2) Subjects who plan to receive surgical treatment at the same time during cerebrovascular angiography 3) Allergic to or intolerant to iodized contrast media 4) Allergy to interventional devices 5) severe heart, liver and kidney insufficiency 6) Active systemic infection exists 7) Severe vascular stenosis, occlusion or skin infection at the puncture site 8) Subjects with severe coagulopathy, bleeding tendency, or contraindication of anticoagulant drugs (such as heparin) 9) Subjects who have been enrolled in clinical studies of other devices or drugs for 3 months prior to screening 10) Female subjects of childbearing age during pregnancy and lactation 11) Other subjects deemed unsuitable for this study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Success rate of superselected technology;Target vessel superselection operation time;Perspective time;The main surgeon absorbed radiation dose;Radiation absorbed dose of subject;Instrument performance evaluation; | — |
Countries
china
Contacts
The First Affiliated Hospital of Naval Medical University(Shanghai Changhai)